IIFL is bullish on Natco Pharma and has recommended buy rating on the stock with a target of Rs 339 in its January 5, 2011 research report.
After hitting all time peak of Rs 357 in the month of December 2010, stock has been consolidating in a triangle pattern with volumes dipping, prices moves nearer to the apex. However stock has signaled a breakout from the triangle in yesterdays trading session with spurt in volumes. The breakout was also backed up with 'golden cross' from short term moving averages and positive crossover in the RSI. As the amplitude of triangle corresponds to 40 points, we expect stock to rally towards levels of Rs 338 in the near term. We advise buying stock above Rs 319 with stop loss of Rs 309 for target of Rs 339. (Time period for 7 days)," says IIFL research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.Moneycontrol.com advises users to check with certified experts before taking any investment decisions.